Natalie Shapnik

Next-generation sequencing based detection of germline and somatic alterations in a patient with four metachronous primary tumors

G. Turashvili, D. Halpenny, H. Rizvi, 2018, Gynecologic oncology reports.

Myocarditis with tremelimumab plus durvalumab combination therapy for endometrial cancer: A case report

Syed S Mahmood, Harsimran S. Singh, U. Krishnan, 2018, Gynecologic oncology reports.

Matched Molecular Profiling of Cell-Free DNA and Tumor Tissue in Patients With Advanced Clear Cell Renal Cell Carcinoma.

M. Ladanyi, M. Berger, R. Motzer, 2022, JCO precision oncology.

Progression-free Survival After Second Line of Therapy for Metastatic Clear Cell Renal Cell Carcinoma in Patients Treated with First-line Immunotherapy Combinations.

R. Motzer, M. Voss, Chung-Han Lee, 2022, European urology.

Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Results of a phase 2 trial.

R. Motzer, M. Voss, E. Reznik, 2021 .

Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non–Clear-Cell Renal Cell Carcinoma and Genomic Correlates

R. Motzer, M. Voss, E. Reznik, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma

R. Motzer, P. Russo, A. Hakimi, 2021, Clinical Cancer Research.

Systemic therapy for advanced clear cell renal cell carcinoma after discontinuation of immune-oncology and VEGF targeted therapy combinations

R. Motzer, O. Akin, M. Voss, 2020, BMC Urology.